2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Iron Deficiency Injectable Market?

The escalating occurrence of polycystic ovary syndrome (PCOS) is predicted to fuel the iron deficiency injectables market’s expansion in the future. This common hormonal disorder, which primarily affects women of reproductive age with ovaries, leads to excessive iron, resulting in excessive blood loss during menstruation and subsequent anemia. Injectable iron deficiency treatments can alleviate this. For example, in June 2023, the World Health Organization, a global special health organization based in the US, reported that PCOS affects approximately 8–13% of women of reproductive age worldwide, with 70% remaining undiagnosed. Consequently, the increasing prevalence of PCOS is stimulating the growth of the iron deficiency injectables market. The increase in malnutrition cases is another critical driver for the iron deficiency injectables market’s growth. Malnutrition, which is characterized by an imbalance between a person’s intake of essential nutrients and their nutritional needs, is a health condition. Iron deficiency injectables are useful in treating malnourished patients as they swiftly replenish the body’s iron reserves and supply a high concentration of iron that the bloodstream rapidly absorbs, thereby quickly rectifying the deficiency. For instance, the California Department of Public Health, a state-level governmental agency in the US, reported in March 2023 that deaths due to malnutrition rose to 1,406 in 2022, a 22.36% increase from the 1,149 deaths reported in 2021. Therefore, the rising prevalence of malnutrition is predicted to boost the iron deficiency injectables market’s growth in the future.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12907&type=smp

#How Will the CAGR of the Iron Deficiency Injectable Market Influence Its Overall Growth by 2034?

In recent times, the market size for injectable treatments for iron deficiency has seen robust growth. The market, which is projected to rise from $14.06 billion in 2024 to $15.37 billion in 2025, boasts a compound annual growth rate (CAGR) of 9.3%. The substantial growth witnessed in the historical period is credited to the high demand for treatments for iron deficiency anemia, patients who have undergone bariatric surgery, the pediatric and adolescent population, and increasing pregnancies.

In the coming years, the market size for injectable treatments for iron deficiency is projected to expand swiftly, reaching a value of $23.13 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.8%. This growth during the prediction period can be traced back to factors such as the aging population, worldwide health initiatives, governmental drives, escalated treatments for enduring illnesses, and rapid replenishment of iron. Major trends that are anticipated in the forecasting period include the development in iron formulations, the prominence of digital health solutions, innovation in injectable therapy for iron deficiency, and an increase in the use of iron-dependent drugs.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12907

What New Market Trends Are Reshaping the Iron Deficiency Injectable Market and Its Opportunities?

Leading firms in the iron deficiency injectables market, such as the US-based Daiichi Sankyo Company and American Regent Inc., are innovating with new treatment options like INJECTAFER to maintain their market standing. In June 2023, these two companies introduced INJECTAFER (ferric carboxymaltose injection), a treatment for iron deficiency that gained approval from the Food And Drug Administration, an American governmental body. It is the inaugural and sole intravenous iron replacement therapy for adult patients with ongoing and deteriorating heart failure that has been ratified by the FDA. This endorsement came after scrutinizing over 40 clinical trials involving more than 8,800 international participants using INJECTAFER. This latest authorization strengthens INJECTAFER’s proven successful application in treating patients with iron-deficient anemia and heart failure, including both adults and children.

Who Are the Leading Market Players Fueling Growth in the Iron Deficiency Injectable Market Trend?

Major companies operating in the iron deficiency injectable market are Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH, Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

How is the Global Iron Deficiency Injectable Market Segemented?

The iron deficiency injectable market covered in this report is segmented –

1) By Type: Iron Dextran, Iron Sucrose, Ferric Carboxymaltose

2) By Branded or Generics: Branded, Generics

3) By Application: Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Applications

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Iron Dextran: Low Molecular Weight Iron Dextran, High Molecular Weight Iron Dextran

2) By Iron Sucrose: Venofer

3) By Ferric Carboxymaltose: Injectafer, Ferinject

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12907&type=smp

Which Geographics are Influencing the Growth of the Iron Deficiency Injectable Market?

North America was the largest region in the iron deficiency injectable market in 2024. The regions covered in iron deficiency injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Iron Deficiency Injectable Market 2025, By The Business Research Company:

Patient Blood Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Hemoglobin Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Stem Cell/Cord Blood Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: